MUC1 Vaccine in Preventing Lung Cancer in Current and Former Smokers at High Risk for Lung Cancer
Clinical trial NCT03300817 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03300817
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-27
- Primary completion
- 2021-09-23
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.